Literature DB >> 12655563

Identification of seven novel mutations in the GAN gene.

P Bomont1, C Ioos, C Yalcinkaya, R Korinthenberg, J M Vallat, S Assami, A Munnich, B Chabrol, G Kurlemann, M Tazir, M Koenig.   

Abstract

Giant axonal neuropathy (GAN) is a severe early onset neurodegenerative disorder affecting both the peripheral nerves and the central nervous system. The diagnosis is based on the presence of characteristic giant axons on nerve biopsy. In GAN, the integrity of the intermediate filament network is altered. Indeed, abnormal accumulation of the intermediate filaments has been reported in different cell types, including in the swollen axons, which are filled with neurofilaments. We identified the defective protein, gigaxonin, of unknown function, and reported fourteen distinct mutations in twelve families of various origins. Two additional mutations have been recently reported. In the present study, we analysed the GAN gene in 6 families, and identified seven novel mutations: three nonsense and two missense mutations and two deletions. In addition, the molecular result for an already reported family was re-evaluated. In this family, the R269Q "polymorphism" is in fact the pathogenic mutation. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655563     DOI: 10.1002/humu.9122

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

1.  Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling.

Authors:  Shih-Ching Lo; Xuchu Li; Michael T Henzl; Lesa J Beamer; Mark Hannink
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

2.  Giant axonal neuropathy: clinical and genetic study in six cases.

Authors:  E Demir; P Bomont; S Erdem; L Cavalier; M Demirci; G Kose; S Muftuoglu; A N Cakar; E Tan; S Aysun; M Topcu; P Guicheney; M Koenig; H Topaloglu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

3.  Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation.

Authors:  Saleemulla Mahammad; S N Prasanna Murthy; Alessandro Didonna; Boris Grin; Eitan Israeli; Rodolphe Perrot; Pascale Bomont; Jean-Pierre Julien; Edward Kuczmarski; Puneet Opal; Robert D Goldman
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

4.  A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice.

Authors:  Yan Jiao; Xiudong Jin; Jian Yan; Chi Zhang; Feng Jiao; Xinmin Li; Bruce A Roe; David B Mount; Weikuan Gu
Journal:  Genomics       Date:  2008-03-14       Impact factor: 5.736

5.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

6.  Intermediate filament aggregates cause mitochondrial dysmotility and increase energy demands in giant axonal neuropathy.

Authors:  Eitan Israeli; Dilyan I Dryanovski; Paul T Schumacker; Navdeep S Chandel; Jeffrey D Singer; Jean P Julien; Robert D Goldman; Puneet Opal
Journal:  Hum Mol Genet       Date:  2016-03-21       Impact factor: 6.150

7.  Giant axonal neuropathy: a multicenter retrospective study with genotypic spectrum expansion.

Authors:  Andoni Echaniz-Laguna; Jean-Marie Cuisset; Lucie Guyant-Marechal; Patrick Aubourg; Laurent Kremer; Naziha Baaloul; Alain Verloes; Kouider Beladgham; Jimmy Perrot; Bruno Francou; Philippe Latour
Journal:  Neurogenetics       Date:  2019-10-26       Impact factor: 2.660

8.  Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway.

Authors:  Don W Cleveland; Koji Yamanaka; Pascale Bomont
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150

9.  Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice.

Authors:  Thibault Ganay; Alexia Boizot; Renaud Burrer; Jean Paul Chauvin; Pascale Bomont
Journal:  Mol Neurodegener       Date:  2011-04-12       Impact factor: 14.195

10.  New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy.

Authors:  Henry Houlden; Mike Groves; Zosia Miedzybrodzka; Helen Roper; Tracey Willis; John Winer; Gaynor Cole; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-06-19       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.